Onasemnogen-Abeparvovec (ausgesetzt) (Zolgensma®) – Spinal muscular atrophy (SMA)

1. Characteristics

Start date 01.07.2020
Resolution 03.12.2020 revoked
INN Onasemnogen-Abeparvovec
Brand name Zolgensma®
Company AveXis
ATC code M09AX09
DDD 1 U P
Therapeutic area Metabolic diseases METABOL ORPHAN
Reason for procedure not completed: SUSPENDED
Regulatory status Conditional Approval ATMP
Specialties Register study

9. Associated procedures

Resolution INN Brand name Indication Additional benefit


<< List of all resolutions